Skip to main content

Advertisement

Fig. 6 | Fluids and Barriers of the CNS

Fig. 6

From: Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding

Fig. 6

Aβ plasma levels following ADAM10 modulation in a mouse model of AD. The ADAM10 inhibitor GI254023X (200 mg/kg) or vehicle (DMSO) was administered via intraperitoneal injection once per day for five consecutive days to PSAPP mice (35 weeks of age). One hour after the final injection, the plasma was collected and probed for a Aβ40 and b Aβ42 by ELISA. Values represent mean ± SEM (n = 8–9) and are expressed as the amount of Aβ40 or Aβ42 per ml of plasma. Statistical analyses were performed using an unpaired t test

Back to article page